MedPlus subsidiary Optival Health Solutions received a 5-day drug license suspension for a Nashik store from Maharashtra FDA.
The suspension order was received on May 6, 2026, citing violations under Drugs and Cosmetics Act Rule 65.
The company estimates a potential revenue loss of ₹0.75 lakhs due to the temporary store closure.